HYDROCORTISONE CREAM 1%

HYDROCORTISONE CREAM 1% was reported 68237 times

HYDROCORTISONE CREAM 1% is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN BOCAVIRUS INFECTION 113 0.5979
1 VAGINAL FLATULENCE 138 0.4554
2 LYMPHOID TISSUE HYPOPLASIA 68 0.4444
3 THYMUS HYPOPLASIA 73 0.4195
4 C-REACTIVE PROTEIN 353 0.3808
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 754 0.3764
6 GRIP STRENGTH 86 0.3755
7 TOPICAL STEROID WITHDRAWAL REACTION 146 0.3753
8 LUPUS VULGARIS 456 0.3619
9 RHEUMATIC FEVER 1547 0.3467
10 SWOLLEN JOINT COUNT INCREASED 1089 0.3412
11 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 225 0.3368
12 FACET JOINT SYNDROME 1069 0.3280
13 SWOLLEN JOINT COUNT 72 0.2880
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 592 0.2854
15 CYSTITIS BACTERIAL 96 0.2840
16 NOROVIRUS TEST POSITIVE 88 0.2708
17 DISLOCATION OF VERTEBRA 579 0.2536
18 DUODENAL ULCER PERFORATION 1885 0.2532
19 X-RAY ABNORMAL 452 0.2525
20 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1785 0.2489
21 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 139 0.2478
22 STEROID DEPENDENCE 216 0.2460
23 RHEUMATOID FACTOR POSITIVE 1395 0.2413
24 STEROID WITHDRAWAL SYNDROME 238 0.2329
25 CRANIOPHARYNGIOMA 73 0.2199
26 ADRENOCORTICAL INSUFFICIENCY ACUTE 426 0.2181
27 MYCOBACTERIUM CHELONAE INFECTION 155 0.2097
28 RETINITIS 362 0.2094
29 APPENDICOLITH 79 0.2041
30 ANALGESIC THERAPY 63 0.1963
31 HYPOCHOLESTEROLAEMIA 69 0.1955
32 PERIPHERAL VENOUS DISEASE 782 0.1913
33 SECONDARY IMMUNODEFICIENCY 229 0.1885
34 CATARRH 169 0.1869
35 ABSCESS BACTERIAL 66 0.1818
36 HELICOBACTER INFECTION 1865 0.1813
37 ADRENAL SUPPRESSION 149 0.1767
38 PEMPHIGUS 2059 0.1645
39 C-REACTIVE PROTEIN ABNORMAL 1036 0.1613
40 PORPHYRIA ACUTE 230 0.1603
41 MUSCLE INJURY 1300 0.1567
42 HAND DEFORMITY 2014 0.1534
43 FOLLICULITIS 1537 0.1464
44 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 934 0.1437
45 CORONA VIRUS INFECTION 60 0.1395
46 OVERLAP SYNDROME 96 0.1371
47 HYPOFIBRINOGENAEMIA 128 0.1290
48 BREAST CANCER STAGE III 832 0.1283
49 PERICARDITIS 2058 0.1224
50 SYNOVITIS 2098 0.1162
51 LIP DRY 1037 0.1141
52 PSEUDOMONAL SEPSIS 197 0.1124
53 SERONEGATIVE ARTHRITIS 125 0.1091
54 ONYCHOMADESIS 454 0.1081
55 DRUG TOLERANCE DECREASED 299 0.1064
56 FEMALE GENITAL TRACT FISTULA 181 0.1059
57 PARAINFLUENZAE VIRUS INFECTION 150 0.0985
58 FEBRILE BONE MARROW APLASIA 410 0.0964
59 GRIP STRENGTH DECREASED 840 0.0953
60 ONYCHOMYCOSIS 418 0.0952
61 GLOSSODYNIA 2112 0.0942
62 HYPERCHOLESTEROLAEMIA 909 0.0941
63 BURNS SECOND DEGREE 165 0.0940
64 JOINT RANGE OF MOTION DECREASED 1250 0.0931
65 LIVE BIRTH 765 0.0914
66 HUMAN HERPESVIRUS 6 INFECTION 168 0.0888
67 BONE EROSION 309 0.0873
68 BURSITIS 1039 0.0855
69 WOUND INFECTION 936 0.0854
70 SECONDARY ADRENOCORTICAL INSUFFICIENCY 124 0.0821
71 GRAFT LOSS 59 0.0814
72 DEATH NEONATAL 113 0.0812
73 WOUND 2222 0.0794
74 ENTEROBACTER INFECTION 133 0.0791
75 ADRENAL INSUFFICIENCY 939 0.0773
76 BLEPHAROSPASM 483 0.0766
77 AUTOIMMUNE DISORDER 736 0.0754
78 RADICULOPATHY 188 0.0713
79 IRRITABLE BOWEL SYNDROME 1509 0.0703
80 BODY TEMPERATURE FLUCTUATION 145 0.0695
81 SYSTEMIC LUPUS ERYTHEMATOSUS 2437 0.0686
82 FIBROMYALGIA 1648 0.0677
83 VIRAEMIA 93 0.0671
84 DIABETES INSIPIDUS 158 0.0656
85 PROCTITIS 183 0.0653
86 DIFFUSE ALVEOLAR DAMAGE 75 0.0652
87 DRUG LEVEL BELOW THERAPEUTIC 356 0.0645
88 CHRONIC SINUSITIS 238 0.0633
89 PITUITARY TUMOUR BENIGN 99 0.0607
90 TYPE 2 DIABETES MELLITUS 1946 0.0577
91 LIVER INJURY 1374 0.0559
92 NAIL DISORDER 483 0.0551
93 HYPOPITUITARISM 96 0.0551
94 CORTISOL DECREASED 62 0.0542
95 SKIN WEEPING 193 0.0540
96 CYTOMEGALOVIRUS CHORIORETINITIS 105 0.0538
97 OBESITY 849 0.0532
98 FINGER DEFORMITY 256 0.0528
99 INFUSION RELATED REACTION 3502 0.0528
100 SCIATICA 840 0.0526
101 CONTRAINDICATED PRODUCT ADMINISTERED 1595 0.0526
102 PRODUCT LABEL CONFUSION 305 0.0523
103 FAECAL CALPROTECTIN INCREASED 165 0.0521
104 MATERNAL EXPOSURE TIMING UNSPECIFIED 192 0.0511
105 HYPOPNOEA 174 0.0501
106 BRONCHIECTASIS 332 0.0492
107 IMPAIRED HEALING 1604 0.0488
108 RHINOVIRUS INFECTION 190 0.0488
109 HYPOPHYSITIS 98 0.0487
110 PNEUMATOSIS INTESTINALIS 137 0.0480
111 PUSTULAR PSORIASIS 163 0.0474
112 GASTROENTERITIS NOROVIRUS 63 0.0474
113 PULMONARY FIBROSIS 904 0.0471
114 EXOSTOSIS 428 0.0468
115 BLOOD PRESSURE FLUCTUATION 1088 0.0453
116 ULCER HAEMORRHAGE 304 0.0449
117 PSORIATIC ARTHROPATHY 1817 0.0447
118 LOWER LIMB FRACTURE 834 0.0434
119 EYE INJURY 131 0.0431
120 ANAL FISSURE 231 0.0430
121 APLASTIC ANAEMIA 222 0.0425
122 STRONGYLOIDIASIS 68 0.0421
123 PRESCRIBED OVERDOSE 809 0.0418
124 WALKING AID USER 275 0.0417
125 ADRENAL DISORDER 80 0.0416
126 CONGENITAL ANOMALY 315 0.0407
127 INTENTIONAL PRODUCT USE ISSUE 3539 0.0404
128 LOWER RESPIRATORY TRACT INFECTION 1830 0.0402
129 ALCOHOL POISONING 106 0.0395
130 NORMAL NEWBORN 214 0.0393
131 LUPUS-LIKE SYNDROME 357 0.0393
132 COELIAC DISEASE 386 0.0393
133 BLOOD CHOLESTEROL INCREASED 1810 0.0388
134 RASH VESICULAR 187 0.0386
135 BREAST CANCER STAGE II 315 0.0378
136 CUSHINGOID 121 0.0377
137 DRUG LEVEL ABOVE THERAPEUTIC 170 0.0371
138 HYPERPHOSPHATAEMIA 79 0.0367
139 RED BLOOD CELL SEDIMENTATION RATE INCREASED 404 0.0365
140 ARTHROPATHY 2027 0.0364
141 GAIT INABILITY 1202 0.0359
142 BACK INJURY 388 0.0356
143 BLOOD PRESSURE DIASTOLIC DECREASED 259 0.0351
144 BRONCHOPULMONARY ASPERGILLOSIS 271 0.0349
145 BLISTER 1944 0.0346
146 PRESCRIBED UNDERDOSE 681 0.0341
147 SERUM SICKNESS 95 0.0341
148 BLOOD PHOSPHORUS INCREASED 92 0.0337
149 HEPATIC ENZYME INCREASED 2260 0.0331
150 ASPERGILLUS INFECTION 216 0.0329
151 POOR VENOUS ACCESS 335 0.0323
152 LEUKOENCEPHALOPATHY 120 0.0322
153 CLOSTRIDIUM DIFFICILE COLITIS 340 0.0320
154 THERAPEUTIC PRODUCT EFFECT DECREASED 1423 0.0317
155 HYPERTRIGLYCERIDAEMIA 184 0.0314
156 FOOT DEFORMITY 348 0.0314
157 DRUG SPECIFIC ANTIBODY PRESENT 203 0.0312
158 FREQUENT BOWEL MOVEMENTS 842 0.0311
159 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 531 0.0309
160 DISCOMFORT 1883 0.0308
161 ERYTHEMA NODOSUM 108 0.0307
162 STOMATITIS 1858 0.0306
163 WHEEZING 1816 0.0306
164 NIGHT SWEATS 986 0.0306
165 HIP ARTHROPLASTY 467 0.0305
166 JOINT DISLOCATION 318 0.0301
167 DRUG LEVEL DECREASED 299 0.0293
168 C-REACTIVE PROTEIN INCREASED 1059 0.0291
169 OSTEOARTHRITIS 1231 0.0290
170 ESCHERICHIA BACTERAEMIA 68 0.0289
171 KOUNIS SYNDROME 65 0.0286
172 ENTERITIS 183 0.0286
173 INFUSION SITE REACTION 85 0.0284
174 CYTOMEGALOVIRUS VIRAEMIA 126 0.0283
175 GINGIVAL PAIN 222 0.0279
176 TEMPERATURE REGULATION DISORDER 62 0.0278
177 SPONDYLITIS 101 0.0277
178 BACTERIAL INFECTION 513 0.0275
179 OESOPHAGEAL CANDIDIASIS 109 0.0273
180 APHTHOUS ULCER 212 0.0273
181 SWELLING 2524 0.0269
182 BLOOD PRESSURE DIASTOLIC INCREASED 124 0.0268
183 KLEBSIELLA INFECTION 135 0.0267
184 INFLAMMATION 1363 0.0264
185 HYPERCAPNIA 78 0.0259
186 SYSTEMIC CANDIDA 65 0.0259
187 RHINITIS 208 0.0258
188 OEDEMA 1382 0.0255
189 MOBILITY DECREASED 1829 0.0254
190 TASTE DISORDER 512 0.0252
191 MATERNAL EXPOSURE DURING PREGNANCY 2244 0.0252
192 STAPHYLOCOCCAL SEPSIS 124 0.0251
193 HYPERNATRAEMIA 125 0.0251
194 BLOOD CULTURE POSITIVE 75 0.0250
195 VENOUS THROMBOSIS 98 0.0249
196 LARGE INTESTINAL ULCER 66 0.0243
197 OXYGEN SATURATION ABNORMAL 69 0.0243
198 ROAD TRAFFIC ACCIDENT 1017 0.0243
199 INJURY 1706 0.0242
200 ENTEROCOCCAL INFECTION 117 0.0242
201 BODY TEMPERATURE DECREASED 238 0.0242
202 EPILEPSY 727 0.0238
203 COLITIS ULCERATIVE 1063 0.0238
204 DRUG INTOLERANCE 2287 0.0237
205 ORAL CANDIDIASIS 310 0.0235
206 IRON DEFICIENCY 105 0.0233
207 CARDIAC MURMUR 202 0.0233
208 SLEEP DISORDER 1646 0.0233
209 PAROSMIA 175 0.0232
210 WEIGHT FLUCTUATION 241 0.0230
211 MUCOSAL INFLAMMATION 603 0.0230
212 MYOSITIS 206 0.0229
213 LUNG DISORDER 1124 0.0229
214 FEBRILE NEUTROPENIA 1501 0.0226
215 NEUTROPENIC SEPSIS 161 0.0225
216 HYPOPHOSPHATAEMIA 165 0.0223
217 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
218 LIVER FUNCTION TEST INCREASED 475 0.0221
219 GENERAL PHYSICAL HEALTH DETERIORATION 2545 0.0220
220 MUSCULOSKELETAL STIFFNESS 1920 0.0219
221 ADVERSE REACTION 289 0.0218
222 ILL-DEFINED DISORDER 1323 0.0218
223 IMPAIRED QUALITY OF LIFE 313 0.0217
224 KNEE ARTHROPLASTY 457 0.0217
225 DELIRIUM 752 0.0216
226 BACTERIAL SEPSIS 70 0.0215
227 ESCHERICHIA SEPSIS 62 0.0214
228 HEART RATE DECREASED 750 0.0213
229 DRUG-INDUCED LIVER INJURY 666 0.0212
230 TREATMENT FAILURE 1739 0.0210
231 JOINT SWELLING 2533 0.0210
232 EXPOSURE DURING PREGNANCY 1304 0.0210
233 RHEUMATOID ARTHRITIS 2376 0.0209
234 GRAFT VERSUS HOST DISEASE 149 0.0207
235 DERMATITIS EXFOLIATIVE GENERALISED 72 0.0207
236 NEOPLASM RECURRENCE 70 0.0206
237 RECTAL HAEMORRHAGE 885 0.0206
238 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 104 0.0205
239 THERAPY NON-RESPONDER 921 0.0205
240 ANAL FISTULA 109 0.0204
241 SKIN ATROPHY 116 0.0201
242 INFUSION SITE EXTRAVASATION 125 0.0201
243 LIVER DISORDER 890 0.0200
244 GROWTH RETARDATION 59 0.0200
245 MUSCULOSKELETAL PAIN 1048 0.0200
246 HERPES SIMPLEX 130 0.0200
247 HEPATIC CIRRHOSIS 373 0.0198
248 SUSPECTED OFF LABEL USE 89 0.0197
249 FISTULA 218 0.0194
250 RESPIRATORY ACIDOSIS 76 0.0193
251 BLOOD PRESSURE SYSTOLIC INCREASED 377 0.0193
252 SEPTIC SHOCK 841 0.0193
253 EAR INFECTION 513 0.0193
254 GENERAL SYMPTOM 144 0.0192
255 PSEUDOMONAS INFECTION 163 0.0190
256 PROCTALGIA 122 0.0190
257 HEART RATE IRREGULAR 427 0.0189
258 VAGINAL DISCHARGE 191 0.0189
259 MULTIPLE ORGAN DYSFUNCTION SYNDROME 530 0.0187
260 DRY MOUTH 1518 0.0187
261 RESPIRATORY RATE INCREASED 166 0.0187
262 EAR PAIN 360 0.0185
263 CONDITION AGGRAVATED 5568 0.0183
264 MUCOUS STOOLS 90 0.0182
265 HYPOALBUMINAEMIA 141 0.0181
266 GASTROINTESTINAL DISORDER 1620 0.0181
267 HYPERTRANSAMINASAEMIA 124 0.0178
268 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 170 0.0178
269 STAPHYLOCOCCAL BACTERAEMIA 77 0.0177
270 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 295 0.0174
271 BLOOD URIC ACID INCREASED 100 0.0173
272 AORTIC STENOSIS 60 0.0172
273 VENOOCCLUSIVE LIVER DISEASE 84 0.0170
274 ABDOMINAL DISCOMFORT 2852 0.0170
275 BACTERAEMIA 201 0.0169
276 SINUSITIS 1722 0.0168
277 DYSPEPSIA 1653 0.0168
278 PARAESTHESIA ORAL 242 0.0168
279 RED CELL DISTRIBUTION WIDTH INCREASED 69 0.0166
280 RALES 96 0.0165
281 MIGRAINE 1577 0.0165
282 SPINAL FUSION SURGERY 67 0.0165
283 PNEUMOCYSTIS JIROVECII PNEUMONIA 165 0.0164
284 CANDIDA INFECTION 277 0.0164
285 RESPIRATORY DISORDER 489 0.0163
286 HYPERBILIRUBINAEMIA 168 0.0162
287 NEPHROGENIC ANAEMIA 75 0.0162
288 ANAL ABSCESS 87 0.0161
289 TOXIC EPIDERMAL NECROLYSIS 242 0.0159
290 JOINT STIFFNESS 417 0.0159
291 SKIN INFECTION 178 0.0159
292 APPENDICITIS 148 0.0158
293 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 760 0.0158
294 CONTUSION 1509 0.0157
295 BODY TEMPERATURE INCREASED 319 0.0156
296 OSTEOPOROSIS 639 0.0155
297 PAPULE 109 0.0155
298 URTICARIA 2578 0.0154
299 COLITIS 581 0.0153
300 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1079 0.0152
301 HYPERSENSITIVITY 2798 0.0151
302 CARDIOGENIC SHOCK 216 0.0150
303 ENCEPHALITIS 103 0.0149
304 DISABILITY 292 0.0148
305 ECZEMA 772 0.0147
306 UVEITIS 200 0.0147
307 HYPERTENSION 3118 0.0147
308 TUMOUR LYSIS SYNDROME 129 0.0146
309 HEPATITIS 369 0.0144
310 CONFUSIONAL STATE 2323 0.0144
311 PREGNANCY 286 0.0143
312 HYPOAESTHESIA 2121 0.0142
313 HYDROCEPHALUS 77 0.0141
314 VIRAL INFECTION 468 0.0140
315 SKIN PLAQUE 118 0.0140
316 ATELECTASIS 135 0.0140
317 SKIN WARM 81 0.0139
318 INFECTION 1999 0.0138
319 ABSCESS 219 0.0137
320 HYPONATRAEMIA 773 0.0137
321 ALOPECIA 2694 0.0137
322 HAEMATOCHEZIA 754 0.0136
323 ARTERIOSCLEROSIS CORONARY ARTERY 90 0.0136
324 MACULAR DEGENERATION 162 0.0136
325 BENIGN PROSTATIC HYPERPLASIA 70 0.0135
326 BACK DISORDER 220 0.0135
327 CLOSTRIDIUM DIFFICILE INFECTION 295 0.0135
328 TUBULOINTERSTITIAL NEPHRITIS 253 0.0135
329 POLYARTHRITIS 71 0.0135
330 ACUTE RESPIRATORY DISTRESS SYNDROME 238 0.0134
331 HYPOKALAEMIA 620 0.0134
332 BLOOD THYROID STIMULATING HORMONE DECREASED 61 0.0134
333 VENTRICULAR FIBRILLATION 149 0.0134
334 ORAL DISORDER 98 0.0134
335 MEDICATION ERROR 743 0.0134
336 ARTHRITIS INFECTIVE 62 0.0134
337 WEIGHT INCREASED 2992 0.0133
338 VASCULAR DEVICE INFECTION 60 0.0132
339 THERAPEUTIC RESPONSE SHORTENED 437 0.0132
340 NEURALGIA 316 0.0130
341 VAGINAL INFECTION 61 0.0129
342 HYPOVOLAEMIC SHOCK 62 0.0129
343 PERIPHERAL SWELLING 1967 0.0128
344 NASOPHARYNGITIS 2347 0.0127
345 DEFAECATION URGENCY 89 0.0127
346 INFLAMMATORY MARKER INCREASED 62 0.0125
347 DRUG LEVEL INCREASED 205 0.0124
348 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2232 0.0124
349 FAILURE TO THRIVE 64 0.0123
350 MYASTHENIA GRAVIS 99 0.0122
351 INFUSION SITE SWELLING 77 0.0122
352 PRODUCT USE ISSUE 2289 0.0122
353 SEPSIS 1338 0.0120
354 HYPERLIPIDAEMIA 143 0.0120
355 ENDOCARDITIS 61 0.0119
356 OXYGEN SATURATION DECREASED 663 0.0118
357 PYREXIA 4048 0.0117
358 TROPONIN INCREASED 89 0.0117
359 HAEMODYNAMIC INSTABILITY 89 0.0117
360 DRUG TOLERANCE 59 0.0117
361 ACIDOSIS 89 0.0116
362 BLOOD LACTIC ACID INCREASED 61 0.0116
363 RASH 5025 0.0115
364 RESPIRATORY DISTRESS 318 0.0115
365 STREPTOCOCCAL INFECTION 64 0.0115
366 SKIN LESION 315 0.0115
367 HAEMORRHOIDS 223 0.0114
368 ASTHMA 1292 0.0114
369 INFUSION SITE PAIN 147 0.0114
370 UPPER RESPIRATORY TRACT INFECTION 526 0.0114
371 AMNESIA 739 0.0113
372 DIARRHOEA HAEMORRHAGIC 106 0.0113
373 TACHYPNOEA 154 0.0113
374 SKIN SWELLING 98 0.0113
375 ACUTE RESPIRATORY FAILURE 217 0.0113
376 TACHYCARDIA 1001 0.0113
377 ARTHRITIS 886 0.0113
378 PULMONARY HAEMORRHAGE 88 0.0112
379 LUNG INFILTRATION 99 0.0112
380 TENDERNESS 116 0.0111
381 ENCEPHALOPATHY 273 0.0111
382 ENTEROCOLITIS 64 0.0111
383 PRODUCT ADMINISTRATION INTERRUPTED 87 0.0111
384 NEUROTOXICITY 194 0.0111
385 CYTOKINE RELEASE SYNDROME 222 0.0111
386 ORAL HERPES 216 0.0111
387 OFF LABEL USE 9686 0.0111
388 MOUTH ULCERATION 233 0.0110
389 OBSTRUCTIVE AIRWAYS DISORDER 123 0.0110
390 RASH PRURITIC 598 0.0110
391 PRODUCT USE IN UNAPPROVED INDICATION 2723 0.0110
392 THROMBOTIC MICROANGIOPATHY 107 0.0110
393 IMPAIRED WORK ABILITY 234 0.0109
394 ESCHERICHIA INFECTION 90 0.0109
395 SKIN HYPERPIGMENTATION 94 0.0109
396 DISSEMINATED INTRAVASCULAR COAGULATION 154 0.0109
397 ANAPHYLACTIC REACTION 604 0.0109
398 HYPERGLYCAEMIA 398 0.0109
399 NECK PAIN 605 0.0108
400 SKIN FISSURES 211 0.0108
401 SWOLLEN TONGUE 336 0.0107
402 DERMATITIS 225 0.0107
403 APPETITE DISORDER 71 0.0107
404 GASTROENTERITIS 156 0.0107
405 POLYURIA 87 0.0106
406 HYPOXIA 373 0.0106
407 MOUTH SWELLING 61 0.0106
408 ARTHRALGIA 4389 0.0105
409 STAPHYLOCOCCAL INFECTION 348 0.0105
410 CONCOMITANT DISEASE AGGRAVATED 65 0.0105
411 MULTI-ORGAN FAILURE 182 0.0105
412 HYDRONEPHROSIS 78 0.0104
413 GASTROOESOPHAGEAL REFLUX DISEASE 838 0.0104
414 FEELING HOT 637 0.0104
415 BLOOD PRESSURE INCREASED 1587 0.0104
416 MALNUTRITION 116 0.0104
417 CYTOMEGALOVIRUS INFECTION 172 0.0103
418 PALLOR 281 0.0103
419 NEUROLOGICAL SYMPTOM 59 0.0103
420 SKIN LACERATION 112 0.0103
421 LOWER GASTROINTESTINAL HAEMORRHAGE 76 0.0103
422 RESPIRATORY FAILURE 748 0.0102
423 INFUSION SITE ERYTHEMA 86 0.0102
424 END STAGE RENAL DISEASE 186 0.0102
425 RASH ERYTHEMATOUS 487 0.0102
426 LIPASE INCREASED 78 0.0102
427 TOOTH INFECTION 134 0.0102
428 ELECTROLYTE IMBALANCE 118 0.0101
429 MUSCULAR WEAKNESS 1148 0.0101
430 ABDOMINAL PAIN 2346 0.0101
431 COAGULOPATHY 167 0.0100
432 DECREASED APPETITE 2325 0.0100
433 PRURITUS 3831 0.0100
434 SINUS TACHYCARDIA 141 0.0099
435 ASPHYXIA 81 0.0099
436 HYPERTHYROIDISM 143 0.0099
437 ABDOMINAL DISTENSION 1031 0.0099
438 IMMUNOSUPPRESSION 87 0.0099
439 MYOPATHY 85 0.0098
440 ASCITES 289 0.0098
441 LYMPHOPENIA 139 0.0098
442 FUNGAL INFECTION 327 0.0098
443 CHEST PAIN 1817 0.0098
444 TYPE 1 DIABETES MELLITUS 59 0.0098
445 SLEEP APNOEA SYNDROME 186 0.0097
446 PARAESTHESIA 1533 0.0097
447 PHARYNGITIS STREPTOCOCCAL 105 0.0097
448 PANCYTOPENIA 542 0.0097
449 SCRATCH 102 0.0097
450 OEDEMA PERIPHERAL 1178 0.0097
451 ADVERSE DRUG REACTION 868 0.0097
452 WEIGHT DECREASED 2689 0.0096
453 ABDOMINAL PAIN UPPER 1982 0.0096
454 OSTEOPENIA 145 0.0095
455 PERIPHERAL COLDNESS 131 0.0095
456 PANCREATITIS 502 0.0095
457 ASPIRATION 104 0.0095
458 LOW BIRTH WEIGHT BABY 75 0.0094
459 LEFT VENTRICULAR DYSFUNCTION 63 0.0094
460 URINE OUTPUT DECREASED 82 0.0094
461 FEELING COLD 261 0.0094
462 SKIN EXFOLIATION 789 0.0093
463 CELLULITIS 471 0.0093
464 GENERALISED OEDEMA 115 0.0093
465 CYANOSIS 146 0.0093
466 PNEUMONIA 3002 0.0093
467 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 95 0.0092
468 ANAL INCONTINENCE 83 0.0092
469 HEPATIC CYTOLYSIS 117 0.0092
470 HYPOGAMMAGLOBULINAEMIA 60 0.0091
471 RASH MACULO-PAPULAR 203 0.0091
472 CORONAVIRUS INFECTION 60 0.0091
473 RESPIRATORY SYNCYTIAL VIRUS INFECTION 79 0.0091
474 MEMORY IMPAIRMENT 1246 0.0091
475 FLANK PAIN 85 0.0091
476 CROHN'S DISEASE 62 0.0090
477 MUSCLE SPASTICITY 111 0.0090
478 HEPATOCELLULAR INJURY 128 0.0090
479 ORAL PAIN 202 0.0090
480 VASCULITIS 105 0.0090
481 BOWEL MOVEMENT IRREGULARITY 69 0.0090
482 EJECTION FRACTION DECREASED 140 0.0090
483 DIVERTICULUM 64 0.0090
484 HYPERCALCAEMIA 111 0.0090
485 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 67 0.0089
486 HAEMATOCRIT DECREASED 177 0.0089
487 BLOOD SODIUM DECREASED 168 0.0089
488 ERYTHEMA 1820 0.0088
489 SKIN REACTION 124 0.0088
490 IRON DEFICIENCY ANAEMIA 81 0.0088
491 CIRCULATORY COLLAPSE 148 0.0087
492 DERMATITIS CONTACT 99 0.0087
493 WHITE BLOOD CELL COUNT INCREASED 332 0.0086
494 PRODUCTIVE COUGH 413 0.0086
495 TOOTH ABSCESS 88 0.0086
496 BRONCHOSPASM 123 0.0086
497 PNEUMONIA BACTERIAL 79 0.0086
498 HYPOTHERMIA 87 0.0086
499 BLOOD MAGNESIUM DECREASED 74 0.0086
500 TRICUSPID VALVE INCOMPETENCE 68 0.0086
501 VOMITING 4004 0.0085
502 DEVICE RELATED INFECTION 131 0.0085
503 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 70 0.0085
504 ULCER 135 0.0085
505 OROPHARYNGEAL PAIN 781 0.0084
506 MALAISE 3697 0.0084
507 OESOPHAGITIS 92 0.0084
508 PLEURAL EFFUSION 511 0.0084
509 FAECES SOFT 61 0.0084
510 CYSTITIS 267 0.0084
511 CHEST DISCOMFORT 854 0.0083
512 ADVERSE EVENT 766 0.0083
513 GASTROINTESTINAL INFLAMMATION 65 0.0083
514 HYPOTENSION 1664 0.0083
515 UNRESPONSIVE TO STIMULI 214 0.0083
516 SKIN DISORDER 275 0.0082
517 THROMBOCYTOPENIA 922 0.0082
518 SCAB 94 0.0082
519 RASH PUSTULAR 60 0.0082
520 CHOLESTASIS 158 0.0082
521 PREMATURE DELIVERY 131 0.0082
522 BLOOD CALCIUM INCREASED 72 0.0082
523 INTESTINAL PERFORATION 92 0.0082
524 BLOOD ALBUMIN DECREASED 65 0.0082
525 GOUT 147 0.0082
526 INSOMNIA 2178 0.0082
527 PAIN IN EXTREMITY 2407 0.0082
528 PANCREATITIS ACUTE 183 0.0081
529 CONJUNCTIVITIS 151 0.0081
530 MUSCLE SPASMS 1493 0.0081
531 DEEP VEIN THROMBOSIS 527 0.0081
532 DEPRESSION 1845 0.0081
533 SPINAL OSTEOARTHRITIS 71 0.0081
534 HAEMOPTYSIS 225 0.0081
535 HYPOTHYROIDISM 256 0.0080
536 SEASONAL ALLERGY 113 0.0080
537 RHINORRHOEA 516 0.0080
538 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 438 0.0080
539 CARDIOMEGALY 98 0.0080
540 ACUTE KIDNEY INJURY 1218 0.0080
541 ERYTHEMA MULTIFORME 74 0.0079
542 CHILLS 923 0.0079
543 POST PROCEDURAL INFECTION 64 0.0079
544 HYPERTHERMIA 60 0.0079
545 FATIGUE 6090 0.0078
546 RASH MACULAR 272 0.0078
547 DYSPNOEA 4402 0.0078
548 GAIT DISTURBANCE 1486 0.0078
549 GAMMA-GLUTAMYLTRANSFERASE INCREASED 172 0.0078
550 HYPERKALAEMIA 272 0.0077
551 PSORIASIS 1005 0.0077
552 PULMONARY EMBOLISM 729 0.0077
553 SECRETION DISCHARGE 96 0.0077
554 HYPOCALCAEMIA 145 0.0077
555 LUNG INFECTION 119 0.0077
556 PULMONARY MASS 114 0.0076
557 PNEUMONITIS 207 0.0076
558 GASTROINTESTINAL INFECTION 68 0.0076
559 LIP SWELLING 252 0.0076
560 ANURIA 65 0.0075
561 THROAT TIGHTNESS 204 0.0075
562 HEART RATE INCREASED 747 0.0075
563 OROPHARYNGEAL DISCOMFORT 68 0.0075
564 PERICARDIAL EFFUSION 174 0.0075
565 POLYNEUROPATHY 90 0.0075
566 THROAT IRRITATION 337 0.0075
567 ASTHENIA 2822 0.0075
568 PYELONEPHRITIS 65 0.0075
569 PHARYNGITIS 93 0.0075
570 SPUTUM DISCOLOURED 71 0.0075
571 DERMATITIS ALLERGIC 94 0.0075
572 STEVENS-JOHNSON SYNDROME 166 0.0075
573 EMBOLISM 62 0.0075
574 DERMATITIS ATOPIC 393 0.0074
575 TRANSFUSION 78 0.0074
576 STATUS EPILEPTICUS 84 0.0074
577 HYPOGLYCAEMIA 359 0.0074
578 LABORATORY TEST ABNORMAL 218 0.0074
579 NERVE COMPRESSION 68 0.0074
580 FACE OEDEMA 124 0.0073
581 INTESTINAL OBSTRUCTION 277 0.0073
582 PAIN 4510 0.0073
583 BLOOD IRON DECREASED 87 0.0073
584 SKIN HAEMORRHAGE 108 0.0073
585 INCONTINENCE 77 0.0073
586 THERAPEUTIC RESPONSE DECREASED 440 0.0072
587 BRONCHITIS 537 0.0072
588 IMMUNODEFICIENCY 108 0.0072
589 TRANSAMINASES INCREASED 161 0.0072
590 BLOOD PRESSURE DECREASED 481 0.0072
591 RENAL TUBULAR NECROSIS 71 0.0072
592 HEADACHE 4526 0.0072
593 HYPOMAGNESAEMIA 100 0.0072
594 SPINAL COMPRESSION FRACTURE 59 0.0071
595 INJECTION SITE REACTION 491 0.0071
596 FLUSHING 725 0.0071
597 NEUTROPHIL COUNT INCREASED 73 0.0071
598 FLUID RETENTION 362 0.0071
599 DIARRHOEA 4566 0.0071
600 SMALL INTESTINAL OBSTRUCTION 87 0.0071
601 LYMPHADENOPATHY 250 0.0071
602 EMPHYSEMA 71 0.0070
603 SINUS BRADYCARDIA 68 0.0070
604 FOOT FRACTURE 133 0.0070
605 SKIN ULCER 181 0.0070
606 SHOCK 161 0.0070
607 JOINT INJURY 149 0.0070
608 LEUKOCYTOSIS 126 0.0070
609 TINNITUS 318 0.0069
610 ILEUS 86 0.0069
611 ANKLE FRACTURE 107 0.0069
612 ANGIOEDEMA 305 0.0069
613 BONE MARROW FAILURE 140 0.0069
614 NEUROPATHY PERIPHERAL 651 0.0068
615 LEUKOPENIA 342 0.0068
616 RESPIRATORY TRACT INFECTION 178 0.0068
617 UROSEPSIS 63 0.0068
618 METABOLIC ACIDOSIS 218 0.0068
619 PNEUMOTHORAX 108 0.0068
620 BRAIN OEDEMA 86 0.0068
621 CYST 84 0.0068
622 ANAEMIA 1286 0.0067
623 CHOLECYSTITIS 80 0.0067
624 GASTROENTERITIS VIRAL 121 0.0067
625 BACK PAIN 1556 0.0067
626 FLUID OVERLOAD 97 0.0067
627 HEPATOTOXICITY 148 0.0066
628 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 171 0.0066
629 ALANINE AMINOTRANSFERASE INCREASED 408 0.0066
630 BLOOD TEST ABNORMAL 93 0.0066
631 PROCEDURAL PAIN 183 0.0066
632 CONSTIPATION 1437 0.0066
633 SWELLING FACE 429 0.0066
634 HIDRADENITIS 60 0.0066
635 FOETAL EXPOSURE DURING PREGNANCY 533 0.0066
636 NASAL CONGESTION 384 0.0065
637 CYTOPENIA 80 0.0065
638 ACCIDENTAL OVERDOSE 239 0.0065
639 PREMATURE BABY 196 0.0065
640 RED BLOOD CELL COUNT DECREASED 186 0.0065
641 NAUSEA 5129 0.0065
642 PNEUMONIA ASPIRATION 161 0.0064
643 ASPARTATE AMINOTRANSFERASE INCREASED 342 0.0064
644 COVID-19 PNEUMONIA 76 0.0064
645 PHOTOPHOBIA 121 0.0064
646 BLOOD CREATININE INCREASED 418 0.0064
647 MICTURITION URGENCY 73 0.0064
648 ORTHOSTATIC HYPOTENSION 111 0.0064
649 COVID-19 1115 0.0063
650 PAIN IN JAW 180 0.0063
651 EYE DISCHARGE 66 0.0063
652 DEHYDRATION 847 0.0063
653 CHRONIC KIDNEY DISEASE 480 0.0063
654 URINARY TRACT INFECTION 1076 0.0063
655 NEPHROLITHIASIS 289 0.0063
656 NEUTROPENIA 855 0.0063
657 ANXIETY 1788 0.0063
658 DRY SKIN 836 0.0063
659 DIZZINESS 3122 0.0063
660 TOOTHACHE 113 0.0062
661 EYE SWELLING 232 0.0062
662 ATAXIA 74 0.0062
663 BLOOD CALCIUM DECREASED 70 0.0062
664 BLOOD UREA INCREASED 104 0.0062
665 HEPATIC FAILURE 187 0.0062
666 EYE INFECTION 70 0.0062
667 MYOCARDITIS 71 0.0062
668 QUALITY OF LIFE DECREASED 83 0.0062
669 INCORRECT PRODUCT ADMINISTRATION DURATION 134 0.0062
670 BLOOD LACTATE DEHYDROGENASE INCREASED 98 0.0062
671 EYE INFLAMMATION 59 0.0062
672 COUGH 1731 0.0062
673 VERTIGO 376 0.0062
674 SUPRAVENTRICULAR TACHYCARDIA 59 0.0062
675 SPINAL PAIN 72 0.0061
676 PULMONARY OEDEMA 275 0.0061
677 PHARYNGEAL SWELLING 60 0.0061
678 NIGHTMARE 212 0.0061
679 CARDIOMYOPATHY 90 0.0061
680 BASAL CELL CARCINOMA 95 0.0061
681 LETHARGY 350 0.0061
682 BRADYCARDIA 321 0.0060
683 DRUG TOXICITY 82 0.0060
684 MUSCULOSKELETAL CHEST PAIN 93 0.0060
685 LOCALISED INFECTION 145 0.0060
686 VENTRICULAR TACHYCARDIA 99 0.0060
687 ANAPHYLACTIC SHOCK 154 0.0060
688 GASTRITIS 157 0.0060
689 RENAL FAILURE 792 0.0060
690 LYMPHOCYTE COUNT DECREASED 105 0.0059
691 ABDOMINAL PAIN LOWER 150 0.0059
692 LACRIMATION INCREASED 179 0.0059
693 BLOOD BILIRUBIN INCREASED 160 0.0059
694 PRESYNCOPE 144 0.0059
695 GENERALISED TONIC-CLONIC SEIZURE 98 0.0059
696 HYPOTONIA 59 0.0059
697 MENTAL STATUS CHANGES 164 0.0059
698 UNDERDOSE 431 0.0059
699 HYPOAESTHESIA ORAL 89 0.0059
700 TOOTH FRACTURE 65 0.0059
701 SUBARACHNOID HAEMORRHAGE 60 0.0059
702 RASH PAPULAR 132 0.0059
703 RENAL FAILURE ACUTE 248 0.0058
704 TENDONITIS 90 0.0058
705 POOR QUALITY SLEEP 125 0.0058
706 DRUG INEFFECTIVE 7652 0.0058
707 EYE PRURITUS 195 0.0058
708 HAEMOGLOBIN DECREASED 594 0.0058
709 SKIN DISCOLOURATION 265 0.0058
710 PETECHIAE 60 0.0057
711 OSTEOMYELITIS 104 0.0057
712 MYOCARDIAL ISCHAEMIA 65 0.0057
713 THERAPY PARTIAL RESPONDER 89 0.0057
714 LACTIC ACIDOSIS 184 0.0057
715 DYSURIA 209 0.0057
716 KIDNEY INFECTION 111 0.0057
717 DYSPNOEA EXERTIONAL 213 0.0056
718 BLOOD ALKALINE PHOSPHATASE INCREASED 140 0.0056
719 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 294 0.0056
720 PULMONARY HYPERTENSION 117 0.0056
721 NODULE 73 0.0056
722 PALPITATIONS 655 0.0056
723 INFLUENZA 623 0.0056
724 COLD SWEAT 98 0.0056
725 VISUAL IMPAIRMENT 689 0.0056
726 AGRANULOCYTOSIS 103 0.0055
727 POST PROCEDURAL COMPLICATION 106 0.0055
728 DYSPHAGIA 522 0.0055
729 CARDIAC ARREST 454 0.0055
730 HAEMORRHAGE INTRACRANIAL 82 0.0055
731 INFLUENZA LIKE ILLNESS 450 0.0055
732 MYOCLONUS 65 0.0054
733 BURNING SENSATION 382 0.0054
734 RESPIRATORY TRACT CONGESTION 86 0.0054
735 DISEASE RECURRENCE 257 0.0054
736 HERPES ZOSTER 310 0.0054
737 RESTLESS LEGS SYNDROME 98 0.0054
738 BLOOD POTASSIUM DECREASED 162 0.0054
739 SOMNOLENCE 1083 0.0054
740 HEPATIC STEATOSIS 100 0.0054
741 BRAIN FOG 84 0.0054
742 ILLNESS 549 0.0053
743 PHOTOSENSITIVITY REACTION 88 0.0053
744 PULMONARY CONGESTION 70 0.0053
745 REBOUND EFFECT 60 0.0053
746 MITRAL VALVE INCOMPETENCE 60 0.0053
747 RHABDOMYOLYSIS 221 0.0053
748 OCULAR HYPERAEMIA 251 0.0053
749 EOSINOPHILIA 92 0.0052
750 CAESAREAN SECTION 61 0.0052
751 PAIN OF SKIN 141 0.0052
752 ACUTE MYOCARDIAL INFARCTION 154 0.0052
753 ALTERED STATE OF CONSCIOUSNESS 113 0.0052
754 TREATMENT NONCOMPLIANCE 285 0.0052
755 SEIZURE 601 0.0052
756 THYROID DISORDER 80 0.0052
757 HIATUS HERNIA 67 0.0052
758 EYELID OEDEMA 60 0.0052
759 OSTEONECROSIS 169 0.0051
760 NEOPLASM 59 0.0051
761 DIABETES MELLITUS 391 0.0051
762 SNEEZING 115 0.0051
763 EYE DISORDER 168 0.0051
764 GALLBLADDER DISORDER 91 0.0051
765 INTERNATIONAL NORMALISED RATIO INCREASED 145 0.0051
766 HYPOPHAGIA 130 0.0051
767 ECONOMIC PROBLEM 77 0.0051
768 NEUTROPHIL COUNT DECREASED 205 0.0050
769 ANHEDONIA 131 0.0050
770 DRUG INTERACTION 789 0.0050
771 HEMIPARESIS 84 0.0050
772 SINUS DISORDER 98 0.0049
773 INTERVERTEBRAL DISC PROTRUSION 108 0.0049
774 DRY EYE 246 0.0049
775 RASH GENERALISED 126 0.0049
776 HAEMATEMESIS 123 0.0048
777 INSURANCE ISSUE 74 0.0048
778 DISEASE PROGRESSION 572 0.0048
779 GLAUCOMA 93 0.0048
780 NERVOUS SYSTEM DISORDER 150 0.0048
781 HYPERHIDROSIS 619 0.0048
782 HAEMATOMA 124 0.0048
783 MELAENA 105 0.0048
784 TOOTH DISORDER 106 0.0048
785 PLATELET COUNT INCREASED 62 0.0048
786 PROTEINURIA 90 0.0047
787 APHONIA 66 0.0047
788 FLATULENCE 267 0.0047
789 DEPRESSED LEVEL OF CONSCIOUSNESS 186 0.0047
790 BLOOD TRIGLYCERIDES INCREASED 83 0.0047
791 IMPAIRED GASTRIC EMPTYING 64 0.0047
792 BONE PAIN 275 0.0047
793 ACUTE MYELOID LEUKAEMIA 73 0.0047
794 BLOOD POTASSIUM INCREASED 76 0.0047
795 LIMB INJURY 127 0.0047
796 BONE DISORDER 85 0.0047
797 URINARY INCONTINENCE 138 0.0047
798 EPISTAXIS 348 0.0046
799 DYSPHONIA 272 0.0046
800 DYSGEUSIA 345 0.0046
801 CARPAL TUNNEL SYNDROME 65 0.0046
802 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 108 0.0046
803 RIB FRACTURE 95 0.0046
804 SCAR 79 0.0046
805 ACUTE HEPATIC FAILURE 63 0.0046
806 LIVER FUNCTION TEST ABNORMAL 134 0.0046
807 MYALGIA 782 0.0046
808 FEEDING DISORDER 93 0.0046
809 BEDRIDDEN 60 0.0046
810 SYNCOPE 455 0.0045
811 CHOLELITHIASIS 149 0.0045
812 DIPLOPIA 118 0.0045
813 FAECES DISCOLOURED 98 0.0045
814 HEAD DISCOMFORT 80 0.0045
815 SINUS CONGESTION 61 0.0045
816 HERNIA 87 0.0045
817 HOT FLUSH 336 0.0045
818 PERITONITIS 92 0.0044
819 DIVERTICULITIS 123 0.0044
820 PLATELET COUNT DECREASED 473 0.0044
821 APHASIA 133 0.0044
822 SPINAL FRACTURE 88 0.0044
823 NEOPLASM PROGRESSION 152 0.0044
824 CORONARY ARTERY DISEASE 132 0.0044
825 FALL 1447 0.0043
826 LOSS OF CONSCIOUSNESS 556 0.0043
827 DIABETIC KETOACIDOSIS 104 0.0043
828 DISORIENTATION 171 0.0043
829 RETCHING 92 0.0043
830 DYSARTHRIA 162 0.0043
831 RENAL IMPAIRMENT 361 0.0043
832 SKIN BURNING SENSATION 307 0.0043
833 CARDIO-RESPIRATORY ARREST 179 0.0043
834 EATING DISORDER 91 0.0043
835 CATARACT 254 0.0043
836 GASTRIC ULCER 81 0.0043
837 THIRST 76 0.0042
838 LIMB DISCOMFORT 131 0.0042
839 PRODUCT PRESCRIBING ISSUE 92 0.0042
840 MASS 59 0.0042
841 DRUG ERUPTION 74 0.0042
842 CHROMATURIA 94 0.0042
843 DRUG RESISTANCE 106 0.0041
844 POLLAKIURIA 172 0.0041
845 ATRIAL FIBRILLATION 399 0.0041
846 SKIN CANCER 88 0.0041
847 THROMBOSIS 328 0.0041
848 HALLUCINATION, VISUAL 86 0.0041
849 MUSCULOSKELETAL DISCOMFORT 70 0.0041
850 BLOOD URINE PRESENT 77 0.0041
851 URINARY RETENTION 135 0.0040
852 HYPERSOMNIA 115 0.0040
853 MUSCLE TWITCHING 92 0.0040
854 ISCHAEMIC STROKE 71 0.0040
855 ELECTROCARDIOGRAM QT PROLONGED 143 0.0040
856 UPPER LIMB FRACTURE 79 0.0040
857 DISTURBANCE IN ATTENTION 212 0.0039
858 PRODUCT ADMINISTRATION ERROR 79 0.0039
859 PRODUCT PRESCRIBING ERROR 93 0.0039
860 BLOOD PRESSURE ABNORMAL 77 0.0039
861 DYSSTASIA 113 0.0039
862 EYE PAIN 218 0.0039
863 PRODUCT QUALITY ISSUE 524 0.0039
864 PHARYNGEAL OEDEMA 59 0.0038
865 UPPER GASTROINTESTINAL HAEMORRHAGE 64 0.0038
866 SPEECH DISORDER 199 0.0038
867 TREMOR 630 0.0038
868 PRURITUS GENERALISED 82 0.0038
869 FULL BLOOD COUNT DECREASED 76 0.0038
870 GASTROINTESTINAL HAEMORRHAGE 315 0.0038
871 HAEMORRHAGE 394 0.0038
872 MOVEMENT DISORDER 121 0.0038
873 HEAD INJURY 119 0.0038
874 HEPATIC FUNCTION ABNORMAL 139 0.0037
875 CEREBRAL HAEMORRHAGE 133 0.0037
876 INTENTIONAL PRODUCT MISUSE 324 0.0037
877 RESPIRATORY ARREST 102 0.0037
878 MIDDLE INSOMNIA 69 0.0037
879 INTENTIONAL DOSE OMISSION 103 0.0036
880 CARDIAC FAILURE 290 0.0036
881 AGITATION 265 0.0036
882 RESTLESSNESS 132 0.0036
883 HAEMATURIA 123 0.0036
884 WHITE BLOOD CELL COUNT DECREASED 387 0.0036
885 PRODUCT DOSE OMISSION IN ERROR 101 0.0036
886 MENTAL DISORDER 155 0.0036
887 TRANSIENT ISCHAEMIC ATTACK 120 0.0036
888 INCORRECT DOSE ADMINISTERED 806 0.0035
889 VISION BLURRED 484 0.0035
890 DEPRESSED MOOD 186 0.0035
891 SKIN IRRITATION 160 0.0035
892 PSYCHOTIC DISORDER 102 0.0035
893 THINKING ABNORMAL 64 0.0034
894 IRRITABILITY 206 0.0034
895 JAUNDICE 92 0.0034
896 MALIGNANT NEOPLASM PROGRESSION 349 0.0034
897 BLINDNESS 137 0.0034
898 PELVIC PAIN 61 0.0034
899 BALANCE DISORDER 286 0.0033
900 CHOKING 64 0.0033
901 INCREASED APPETITE 62 0.0032
902 PRODUCT DOSE OMISSION ISSUE 940 0.0032
903 SEROTONIN SYNDROME 61 0.0032
904 INTERSTITIAL LUNG DISEASE 153 0.0032
905 DEMENTIA 88 0.0031
906 FEELING ABNORMAL 752 0.0031
907 PANIC ATTACK 114 0.0031
908 HYPOACUSIS 132 0.0031
909 COMA 146 0.0031
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 88 0.0031
911 AGEUSIA 76 0.0030
912 OSTEONECROSIS OF JAW 75 0.0030
913 RENAL INJURY 90 0.0030
914 CRYING 110 0.0030
915 INJECTION SITE PRURITUS 201 0.0030
916 CARDIAC FAILURE CONGESTIVE 241 0.0030
917 HOSPITALISATION 461 0.0030
918 CONVULSION 171 0.0030
919 ANGINA PECTORIS 84 0.0029
920 THERAPEUTIC RESPONSE UNEXPECTED 131 0.0029
921 CEREBROVASCULAR ACCIDENT 494 0.0029
922 DEAFNESS 76 0.0029
923 HALLUCINATION 219 0.0029
924 NERVOUSNESS 151 0.0029
925 MOOD SWINGS 92 0.0029
926 CEREBRAL INFARCTION 70 0.0029
927 EYE IRRITATION 164 0.0028
928 SURGERY 164 0.0028
929 PLASMA CELL MYELOMA 108 0.0028
930 PRODUCT SUBSTITUTION ISSUE 159 0.0028
931 WITHDRAWAL SYNDROME 115 0.0027
932 ARRHYTHMIA 129 0.0027
933 HIP FRACTURE 87 0.0027
934 ACNE 205 0.0027
935 AGGRESSION 135 0.0027
936 MENTAL IMPAIRMENT 65 0.0027
937 INJECTION SITE URTICARIA 64 0.0026
938 COGNITIVE DISORDER 120 0.0026
939 MOOD ALTERED 70 0.0026
940 DYSKINESIA 103 0.0025
941 DEVICE DISLOCATION 109 0.0025
942 OVERDOSE 537 0.0025
943 INJECTION SITE RASH 74 0.0024
944 BONE DENSITY DECREASED 75 0.0024
945 RENAL DISORDER 111 0.0024
946 BLOOD GLUCOSE DECREASED 113 0.0024
947 FEMUR FRACTURE 72 0.0023
948 NEOPLASM MALIGNANT 154 0.0023
949 DEVICE BREAKAGE 93 0.0023
950 APPLICATION SITE ERYTHEMA 60 0.0023
951 SUICIDAL IDEATION 209 0.0023
952 GASTRIC DISORDER 78 0.0023
953 EXPIRED PRODUCT ADMINISTERED 75 0.0023
954 TOXICITY TO VARIOUS AGENTS 380 0.0023
955 EMOTIONAL DISTRESS 268 0.0022
956 DRUG DOSE OMISSION BY DEVICE 166 0.0021
957 EMOTIONAL DISORDER 65 0.0021
958 ABORTION SPONTANEOUS 84 0.0021
959 DRUG EXPOSURE DURING PREGNANCY 71 0.0021
960 ABNORMAL BEHAVIOUR 82 0.0021
961 DEVICE LEAKAGE 89 0.0021
962 THERAPY INTERRUPTED 145 0.0020
963 MYELOSUPPRESSION 73 0.0020
964 UNEVALUABLE EVENT 153 0.0020
965 CARDIAC DISORDER 187 0.0020
966 VISUAL ACUITY REDUCED 66 0.0020
967 INJECTION SITE ERYTHEMA 242 0.0019
968 INJECTION SITE SWELLING 149 0.0019
969 BLOOD GLUCOSE INCREASED 363 0.0019
970 INJECTION SITE BRUISING 151 0.0019
971 DEATH 1622 0.0019
972 MYOCARDIAL INFARCTION 316 0.0018
973 PRODUCT DOSE OMISSION 116 0.0018
974 DEVICE MALFUNCTION 120 0.0017
975 INJECTION SITE PAIN 515 0.0017
976 DRUG EFFECT DECREASED 87 0.0016
977 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 75 0.0016
978 NO ADVERSE EVENT 278 0.0015
979 DEVICE ISSUE 136 0.0015
980 MULTIPLE SCLEROSIS 70 0.0015
981 THERAPY CESSATION 75 0.0015
982 SUICIDE ATTEMPT 82 0.0014
983 DRUG DOSE OMISSION 198 0.0012
984 INTENTIONAL OVERDOSE 76 0.0012
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 83 0.0012
986 INJECTION SITE HAEMORRHAGE 85 0.0011
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 206 0.0010
988 DRUG DEPENDENCE 152 0.0009
989 ACCIDENTAL EXPOSURE TO PRODUCT 88 0.0009
990 BREAST CANCER 76 0.0008
991 DRUG WITHDRAWAL SYNDROME 66 0.0008